The cerebellum plays a critical role in controlling motor coordination and ensuring that movements are precise and balanced. In dogs affected by NCCD, a genetic mutation disrupts normal cerebellar development, leading to premature death of Purkinje cells and other neurons within the cerebellar cortex. These cells are essential for regulating motor function, and their loss results in severe and progressive neurological dysfunction.
Clinical signs of NCCD typically appear very early in life, often within the first few weeks or months after birth. Affected puppies may initially show subtle abnormalities such as mild tremors, delayed motor development, or difficulty standing and walking. As the condition progresses, symptoms become more severe and include pronounced ataxia (loss of coordination), tremors, frequent falling, inability to maintain balance, and abnormal posture. Puppies may also have difficulty nursing, eating, or interacting normally with littermates due to impaired motor control.
In most cases, NCCD is rapidly progressive, and affected puppies experience a significant decline in neurological function over a short period. Unfortunately, because the disease affects essential brain structures during critical developmental stages, it often leads to severe disability and may require humane veterinary intervention.
The NCCD DNA Health Test is designed to identify the specific genetic mutation responsible for Neonatal Cerebellar Cortical Degeneration. Testing is simple, safe, and non-invasive, typically requiring a cheek swab or blood sample. The sample is analyzed in a specialized laboratory to determine whether the dog carries zero, one, or two copies of the mutation. Since DNA remains constant throughout life, testing can be performed at any age, including in breeding dogs and young puppies.
Results are generally reported as:
- Clear (Normal): The dog does not carry the NCCD mutation and cannot pass it to offspring.
- Carrier: The dog carries one copy of the mutation but typically shows no clinical signs. However, it can pass the mutation to future generations.
- Affected/At Risk: The dog carries two copies of the mutation and is expected to develop Neonatal Cerebellar Cortical Degeneration.
Genetic testing for NCCD is highly important for breeders, veterinarians, and dog owners. Breeders can use results to make informed mating decisions that prevent the production of affected puppies and help eliminate the mutation from breeding lines. Avoiding carrier-to-carrier breeding is essential to reduce disease incidence while maintaining healthy genetic diversity.
For dog owners, understanding genetic status helps ensure responsible breeding and early awareness of neurological risk. Since NCCD manifests very early in life and progresses rapidly, early identification of carrier status is the most effective way to prevent suffering in future litters.
The Neonatal Cerebellar Cortical Degeneration (NCCD) Health Test is a reliable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this severe early-onset developmental disorder in future generations.
